MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$46,639,000
EPS
-$0.13
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
0
0
5,485,000
0
Research and development
38,636,000
33,809,000
24,952,000
25,745,000
General and administrative
12,146,000
9,677,000
8,833,000
8,279,000
Impairment of long-lived assets
-
-
0
0
Net gain on lease termination
3,433,000
-
-
-
Total operating expenses
47,349,000
43,486,000
33,785,000
34,024,000
Loss from operations
-47,349,000
-43,486,000
-28,300,000
-34,024,000
Change in fair value of warrant liability
0
0
736,000
292,000
Change in fair value of term loan
1,521,000
1,470,000
1,643,000
1,534,000
Interest income
2,325,000
2,586,000
2,870,000
3,169,000
Interest expense
6,000
9,000
12,000
15,000
Other expense
-88,000
-31,000
-30,000
-37,000
Total other income (expense), net
710,000
1,076,000
449,000
1,291,000
Net loss
-46,639,000
-42,410,000
-27,851,000
-32,733,000
Basic EPS
-0.13
-0.12
-0.078
-0.09
Diluted EPS
-0.13
-0.12
-0.078
-0.09
Basic Average Shares
369,044,040
366,632,827
358,243,055
353,309,524
Diluted Average Shares
369,044,040
366,632,827
358,243,055
353,309,524
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
TSHA Income Statement Sankey Diagram
Sankey diagram visualizing TSHA income statement for the period
Interest income
$2,325,000
(25.07%↑ Y/Y)
Net loss
-$46,639,000
(-73.50%↓ Y/Y)
Total other income
(expense), net
$710,000
(650.39%↑ Y/Y)
Change in fair value of
term loan
$1,521,000
(4.11%↑ Y/Y)
Other expense
-$88,000
(62.87%↑ Y/Y)
Interest expense
$6,000
(-64.71%↓ Y/Y)
Loss from operations
-$47,349,000
(-76.99%↓ Y/Y)
Total operating
expenses
$47,349,000
(64.76%↑ Y/Y)
Net gain on lease
termination
$3,433,000
Research and development
$38,636,000
(91.83%↑ Y/Y)
General and
administrative
$12,146,000
(41.27%↑ Y/Y)
Buy us a coffee
Taysha Gene Therapies, Inc. (TSHA)
Taysha Gene Therapies, Inc. (TSHA)